Lenalidomide and Dexamethasone for Rosai-Dorfman Disease

Clinical trial NCT04924647 · UNKNOWN

Trial details

NCT number: NCT04924647
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Rosai-Dorfman Disease

Start date: 2021-06-08
Primary completion: 2023-12-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.